Drug Company

May 30, 2016 at 15:38 | Source:
US drug regulator gives Establishment Information Report to the injectables company's Ahmedabad facility. Meanwhile, Granules India too gets US FDA nod for its Jeedimetla unit in Telangana.
May 30, 2016 at 15:16 | Source: PTI
"The company has received the Establishment Inspection Report (EIR) from United States Food and Drug Administration (USFDA) for the inspection conducted at its Jeedimetla facility in December 2015," Granules India said in a filing to the BSE.
May 30, 2016 at 09:40 | Source: CNBC-TV18
The fourth-quarter earnings season has come in mostly satisfactory. A revival should lead to an earnings upgrade, says Harendra Kumar, MD - Institutional Equities, Elara Capital.
May 28, 2016 at 15:00 | Source: PTI
"One of the company's US subsidiaries, Sun Pharmaceuticals Industries Inc (SPII), has received a grand jury subpoena from the United States Department of Justice (DoJ), anti-trust division...," the company said in a BSE filing.
May 27, 2016 at 15:24 | Source: PTI
The company's subsidiary Jubilant Biosys and Checkpoint Therapeutics Inc have signed an exclusive, worldwide license deal, under which Checkpoint will assume all its further pre-clinical, clinical development and commercialisation responsibilities, JLS said in a BSE filing.
May 27, 2016 at 12:00 | Source: PTI
The company has received approval from the US Food and Drug Administration (USFDA) for Metronidazole tablets USP, 250 mg and 500 mg, Strides Shasun said in a BSE filing.
May 26, 2016 at 12:00 | Source: PTI
The company has received tentative approval from the US Food and Drug Administration (USFDA) for Efavirenz tablets USP, 600 mg, Strides Shasun said in a regulatory filing.
May 26, 2016 at 10:10 | Source:
The product will be manufactured at company's oral dosage facility at Bangalore and marketed by Strides in the US market.
May 25, 2016 at 14:48 | Source:
The company has received the establishment inspection report (EIR) from US Food and Drug Administration (USFDA) for its sterile and solid dosages facility (Goa Plant II) situated at L-32/33/34 Verna Industrial Estate, Goa.
Messages on Drug Company »


Gold Member


Dr Reddys Labs  

The US market continues to drive growth for Dr Reddy`s and other Indian generic drug companies. What if this paradigm changes in the global context? The US drives the growth but we have to diversify our sources of growth even though the relative importance of the US may not change. Emerging markets

8.53 PM Jun 30th 2014

anil patil

Platinum Member


Aurobindo Pharm  

deal details with the stock exchanges showed. Morgan Stanley Asia Singapore, which is a shareholder of Aurobindo Pharma, sold 17,32,500 shares of the drug company for about Rs 670 apiece, valuing the transaction at Rs 116 crore. Morgan Stanley Asia Singapore held 46.16 lakh shares of Aurobindo Pharma

11.48 AM May 31st 2014


Platinum Member


Dishman Pharma  

Dishman Pharma is likely to move to UC after 28.05.2014. This drug company will find support at Rs.125/- on account of excellent results. Your best time to pick up this stock at the bottom fishing zone.

8.43 PM May 26th 2014


New Member



Drug Policy Control Order (DPCO) put a cap on the prices of 348 essential drugs, is likely to impact domestic revenue generation of both homegrown and multinational drug companies in 2014

12.55 PM May 15th 2014


Platinum Member



, according to data tracker Dealogic. Many drug companies have paid down debt taken on during a buying spree in the earlier 2000s and are now generating lots of cash they want to put to work. Prescription drug makers are also attracted to acquisitions because deals can allow them cut costs and scale back

4.02 PM Apr 22nd 2014


New Member


Aurobindo Pharm buy , rather accumulate Auro even at current levels for a 1-2 year timeframe. these US legalities are nothing new to Indian drug companies,happens all the time !

10.06 AM Apr 17th 2014

Web Messenger

Platinum Member


Sun Pharma  

Source:VC Circle - Sun Pharmaceutical Industries Ltd, the country's top drugmaker by market cap, is acquiring Ranbaxy Laboratories Ltd in an all-stock transaction, creating the world's fifth-largest generics drug company and the largest pharma company in India by far

12.10 PM Apr 8th 2014


Platinum Member


Sun Pharma  

Is it patent dispute with Drug company UCB?

9.16 PM Mar 18th 2014


Gold Member


Vivimed Labs  

I am doctor by profession and knows the value of research and upcoming drugs. COMPANY has spent lot of rs in research and next quarter filing new ADNA / molecules which will drive the earning. you see almost 90% of shares are by institutes or large investor.

12.47 PM Mar 18th 2014

Web Messenger

Platinum Member



Source:Calcutta Telegraph News - Mumbai, Feb. 20: Cipla has entered into an agreement with MSD to market the latter’s anti-HIV drug raltegravir in the country. This is the first time that Cipla is entering into a strategic partnership with a multinational drug company. MSD is the trade name

2.10 PM Feb 21st 2014

Explore Moneycontrol

Copyright © Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of is prohibited.